340 Phase 1 study of AMG 160, a half-life extended BiTE® (bispecific T-cell engager) therapy targeting prostate-specific membrane antigen, in patients with metastatic castration-resistant prostate cancer
| Autor: | Ben Tran, Nabil Adra, Jean-Pascal Machiels, Sylvie Rottey, Tanya Dorff, Lisa Horvath, Matthew Rettig, Martijn Lolkema, Karen Autio, Richard Greil, Shirley Poon, Daniel Tan, Gabor Jurida, Hosein Kouros-Mehr |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: | |
| Zdroj: | Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020) |
| Druh dokumentu: | article |
| ISSN: | 2051-1426 |
| DOI: | 10.1136/jitc-2020-SITC2020.0340 |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|